Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit

Clin Infect Dis. 2006 Jan 15;42(2):170-8. doi: 10.1086/498898. Epub 2005 Dec 13.

Abstract

Background: Glycopeptide-intermediate Staphylococcus aureus (GISA) is emerging as a cause of nosocomial infection and outbreaks of infection and colonization in intensive care units (ICUs). We describe an outbreak of GISA colonization/infection and the ensuing control measures in an ICU and investigate outcomes of the affected patients.

Methods: We describe an outbreak of GISA colonization and infection that affected 21 patients in a medical ICU at a tertiary care teaching hospital, as well as the measures taken to eradicate the GISA strain.

Result: Recognition of the outbreak was difficult. Infections, all of which were severe, were diagnosed in 11 of 21 patients. Patient isolation and barrier precautions failed when used alone. Addition of a stringent policy of restricted admissions, twice daily environmental cleaning, and implementation of hand decontamination with a hydroalcoholic solution led to outbreak termination. This was associated with increases in workload, despite a marked decrease in the number of admissions.

Conclusion: This first description of a large outbreak of GISA colonization and infection underlines the importance of routine GISA-strain detection when methicillin-resistant S. aureus is isolated. Outbreak control may be difficult to achieve.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carrier State
  • Cross Infection
  • Disease Outbreaks*
  • Drug Resistance, Bacterial*
  • Glycopeptides / pharmacology*
  • Hand Disinfection / methods
  • Health Personnel
  • Housekeeping, Hospital
  • Humans
  • Infection Control* / methods
  • Intensive Care Units
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Glycopeptides